Objective To assess the results with colchicine and prednisone as initial single-drug therapy in patients with usual interstitial pneumonia (UIP).Material and Methods We reviewed the serial pulmonary function test results in 22 patients with typical clinical and high-resolution computed tomographic features of UIP who were treated with colchicine as initial single-agent therapy and compared them with a group of 22 historical patients with UIP of similar severity diagnosed by open-lung biopsy who were given prednisone as initial single-drug therapy.Results No significant difference was detected in the rate of decline of pulmonary function or in the time to failure between the two study groups. A trend was suggested for more rapid decline of pulmonary function in the prednisone-treated than in the colchicine-treated group. The design of this study does not allow distinction between a possible beneficial effect of colchicine and a possible adverse effect related to weaning from high-dose prednisone. Colchicine was well tolerated; few side effects other than mild diarrhea were noted in those patients able to take the drug long enough to return for pulmonary function testing at 3 months. In comparison, the side effects of prednisone were more serious and were not always reversible with cessation of therapy.Conclusion This study lends further support to the assumption that colchicine may be a satisfactory and less hazardous substitute for prednisone in the treatment of patients with UIP.

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/an2020/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000255 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd -nk 000255 | SxmlIndent | more

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    an2020
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:BBEF907D54242A6F26DCF42020EDD2F40881EEC2
   |texte=   Colchicine Versus Prednisone as Treatment of Usual Interstitial Pneumonia
}}